Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Effect of PNF + Core Strengthening Exercise in Sub-acute Guillain Barre Syndrome ( PNF-CORE-GBS ) (PNF-CORE-GBS)

7 de noviembre de 2026 actualizado por: University of Lahore

Proprioceptive Neuromuscular Facilitation Combined With Core Strengthening Exercise in Guillain Barre Syndrome Patients

This randomized controlled trial will evaluate the effectiveness of proprioceptive neuromuscular facilitation combined with core strengthening exercises in Guillain barre syndrome patients .A total of 32 participants aged 18-45 years with clinically diagnosed sub-acute GBS will be allocated into two groups. The intervention group will receive PNF techniques combined with core strengthening exercises, while the control group will receive conventional physiotherapy. Both groups will participate in rehabilitation sessions four times per week for eight weeks.The primary outcomes include balance, muscle strength, and functional independence, assessed using the Berg Balance Scale (BBS), Manual Muscle Testing (MMT), and Barthel Index (BI), respectively. Assessments will be conducted at baseline, the fourth week, and the eighth week.The study purpose to determine whether combining PNF with core strengthening exercises provides additional benefits in improving rehabilitation outcomes in patients with sub-acute Guillain-Barré Syndrome.

Descripción general del estudio

Descripción detallada

Guillain-Barré Syndrome (GBS) is an acute immune-mediated inflammatory polyneuropathy characterized by rapidly progressive muscle weakness, diminished or absent deep tendon reflexes, sensory disturbances, impaired balance, and functional limitations in activities of daily living (ADLs). Although most patients recover gradually following the acute phase, many continue to experience persistent muscle weakness, impaired postural control, reduced trunk stability, and decreased functional independence during the subacute stage. Early rehabilitation plays a vital role in maximizing neurological recovery and improving functional outcomes. Conventional physiotherapy is considered a standard rehabilitation approach for patients with subacute GBS and typically includes range of motion exercises, muscle strengthening, balance training, gait training, and functional mobility exercises. However, there is limited evidence regarding the additional benefits of combining Proprioceptive Neuromuscular Facilitation (PNF) with core strengthening exercises in this population. Proprioceptive Neuromuscular Facilitation (PNF) is a therapeutic approach that uses proprioceptive stimulation, resistance, stretching, and coordinated movement patterns to facilitate neuromuscular activation and functional movement. Core strengthening exercises focus on improving trunk stability, pelvic control, postural alignment, and balance.

Although both interventions are used in neurological rehabilitation, evidence regarding the combined application of PNF and core strengthening exercises in patients with sub-acute GBS remains limited. Therefore, this study is designed to evaluate the effectiveness of combining these interventions compared with conventional physiotherapy.

This study is a randomized controlled trial involving 32 participants with clinically diagnosed sub-acute Guillain-Barré Syndrome. Participants will be recruited through non-probability purposive sampling from the Neuro-Medicine Ward and Physiotherapy Outpatient Department of Jinnah Postgraduate Medical Centre (JPMC), Karachi, Pakistan.

Eligible participants will be adults aged 18-45 years, of either gender, diagnosed with GBS and clinically stable for participation in physiotherapy rehabilitation. Participants will be randomly allocated into two groups using the sealed-envelope method. The outcome assessor will be blinded to group allocation.

Participants assigned to Group A will receive Proprioceptive Neuromuscular Facilitation (PNF) combined with core strengthening exercises.

The PNF intervention will include Contract-Relax (CR) and Contract-Relax-Antagonist-Contract (CRAC) techniques applied to the upper and lower extremities. The techniques will involve an initial stretch of approximately 10-20 seconds, followed by resisted muscle contraction lasting 3-6 seconds, with a relaxation period of approximately 2-3 seconds before further stretching.

Core strengthening exercises will include:

  • Pelvic control exercises.
  • Bridging exercises.
  • Curl-up exercises.
  • Curl-ups with diagonal reaching.
  • Bridging with crossed legs.
  • Single-leg bridging.
  • Side-bridging exercises. These exercises will target trunk and pelvic stability, neuromuscular control, and postural function.

*Control Group (Group B)*

Participants assigned to Group B will receive conventional physiotherapy, including:

  • Upper and lower extremity stretching and strengthening exercises.
  • Techniques for normalization of muscle tone.
  • Weight-bearing exercises.
  • Active functional training.
  • Postural control exercises.
  • Conventional balance training. Both groups will receive physiotherapy rehabilitation four times per week over eight weeks.

The study will evaluate the following outcome measures:

  1. Balance: Assessed using the Berg Balance Scale (BBS), which evaluates static and dynamic balance through 14 functional tasks. The total score ranges from 0 to 56.
  2. Muscle Strength: Assessed using Manual Muscle Testing (MMT), which evaluates muscle strength on a grading scale from 0 to 5.
  3. Functional Independence: Assessed using the Barthel Index (BI), which evaluates independence in activities of daily living, including feeding, bathing, dressing, transfers, mobility, and stair climbing. The total score ranges from 0 to 100.

Assessments will be performed at baseline, the fourth week, and the eighth week of the intervention.

The primary objective is to determine whether PNF combined with core strengthening exercises is more effective than conventional physiotherapy in improving balance, muscle strength, and functional independence among patients with sub-acute Guillain-Barré Syndrome.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

32

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Rida Rao, MSPTN
  • Número de teléfono: 03153515825
  • Correo electrónico: ridarao201@gmail.com

Copia de seguridad de contactos de estudio

Ubicaciones de estudio

    • Punjab Province
      • Lahore, Punjab Province, Pakistán, 54000
        • University of Lahore teaching hospital, Lahore

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años a 45 años (Adulto)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • participants diagnosed with Guillain Barré Syndrome (GBS) based on neurological criteria
  • At the subacute or recovery stage of GBS, meaning within two to 12 weeks from disease onset
  • Age ranges from 18 to 45 years
  • Gender does not matter; both males and females can participate
  • Medical stability of the patient and being medically cleared to engage in intensive rehabilitation by a physical Ability to give informed consent

Exclusion Criteria:•Patients with cognitive disabilities and those who cannot follow commands

  • Patients with unstable heart and breathing rates and other systemic disease
  • Patients refusing to give their informed consent
  • Presence of musculoskeletal problems with balance problems (recent fractures, arthritis)

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: PNF+Core strengthening Group

Participants in the experimental group will receive Proprioceptive Neuromuscular Facilitation (PNF) combined with core strengthening exercises versus conventional physiotherapy. The intervention will be administered according to the study protocol over 4 times in week for 8-week period.

Participants in the experimental group will receive PNF techniques, including Contract-Relax (CR) and Contract-Relax-Antagonist-Contract (CRAC), applied to the upper and lower extremities. The intervention will involve an initial stretch of 10-20 seconds, followed by resisted muscle contraction lasting 3-6 seconds, with approximately 2-3 seconds of rest between contractions and subsequent stretching. PNF will be combined with core strengthening exercises during the 8-week rehabilitation program.

Participants in the experimental group will perform core strengthening exercises targeting trunk and pelvic stability. Exercises will include pelvic control exercises, bridging, curl-ups, curl-ups with diagonal reaching, bridging with crossed legs, single-leg bridging, and side bridging. These exercises will be administered in combination with PNF techniques over an 8-week rehabilitation program.

Comparador activo: conventional physiotheraphy Group

conventional physical therapy Participants in the control group will receive conventional physiotherapy according to the standard rehabilitation protocol for patients with subacute Guillain-Barré Syndrome over 4 time per week for 8 week period

Participants in the control group will receive conventional physiotherapy, including stretching and strengthening exercises for the upper and lower extremities, muscle tone normalization techniques, weight-bearing exercises, active functional training, postural control exercises, and conventional balance training. Treatment will be provided four times per week for eight weeks.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Balance
Periodo de tiempo: Baseline , week 4 and week 8

Balance was assessed using the Berg Balance Scale (BBS) . The Berg Balance Scale is a 14-item clinical scale that measures static and dynamic balance. Scores range from 0 to 56, with higher scores indicating better balance and functional performance

Baseline , week 4 and week 8
muscle strength
Periodo de tiempo: Baseline, week 4 and week 8

Muscle strength was assessed using the Medical Research Council (MRC) Manual Muscle Testing scale. Muscle strength is graded from 0 to 5, where 0 indicates no muscle contraction and 5 indicates normal muscle strength. Higher scores indicate better muscle strength.

Baseline, week 4 and week 8
Activities of Daily living (ADL)
Periodo de tiempo: Baseline , week 4 and week 8

Activities of daily living were assessed using the Barthel Index (BI). The Barthel Index measures independence in activities of daily living. Scores range from 0 to 100, with higher scores indicating greater functional independence.

Baseline , week 4 and week 8

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

30 de noviembre de 2026

Finalización primaria (Estimado)

30 de abril de 2027

Finalización del estudio (Estimado)

30 de mayo de 2027

Fechas de registro del estudio

Enviado por primera vez

7 de noviembre de 2026

Primero enviado que cumplió con los criterios de control de calidad

7 de noviembre de 2026

Publicado por primera vez (Actual)

13 de noviembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

13 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

7 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir